Gabriel Tremblay

Gabriel Tremblay has extensive experience in the field of health economics and comparative effectiveness research. Gabriel currently holds the position of Vice President - Health Economics and Comparative Effectiveness (Global) at Cytel. Prior to that, they worked at Purple Squirrel Economics as the Head of Health Economics and Health Technology Assessment, where they focused on cost-effectiveness analysis and comparative effectiveness research for drugs and medical technologies.

Before Purple Squirrel Economics, Gabriel worked at Eisai as the Director of Global Health Economics and Health Technology Assessment (HTA). In this role, they led a team in conducting economic and HTA analyses, developing global models, and supporting local adaptations.

Gabriel also worked as a Senior Health Economist at Adelphi Values, where they provided economic input to clients, conducted economic analyses, and acted as a project lead for the economic and modeling team. Prior to that, they held the role of Health Economist at Raymond Chabot Grant Thornton, where they conducted economic analyses, econometric analysis, and program evaluations in the healthcare sector.

Gabriel began their career as an Analyst in health economics and outcomes research at Bristol-Myers Squibb, where they conducted economic analyses and market and sales modeling. Gabriel also worked as an Economist at AECOM, conducting economic analyses, impact assessments, and data analysis. Gabriel started their career as an Economist at the Ministère de la Culture, des Communications et de la Condition Féminine.

Overall, Gabriel Tremblay has over twelve years of experience in health economics and has produced numerous health economics and health technology assessment analyses, as well as economic submissions to payers in numerous countries.

Gabriel Tremblay has a strong educational background in business administration and health economics. Gabriel pursued a Doctorate in Business Administration (DBA) from Université Jean Moulin (Lyon III) and the Business Science Institute from 2012 to 2015. During this time, their field of study focused on Health Technology Assessment, which involves evaluating the clinical effectiveness and cost-effectiveness of medical interventions.

Additionally, Gabriel Tremblay obtained an Executive Doctorate in Business Administration (DBA) from the Business Science Institute during the same period. Gabriel'sspecialization during this program included Healthcare Decision Making, Health Economics, and Health Technology Assessment.

In 2013 to 2014, Gabriel Tremblay earned a Certificate of Research in Business Administration from the Business Science Institute, further building their expertise in Healthcare Decision Making, Health Economics, and Health Technology Assessment.

Prior to their DBA programs, Gabriel Tremblay obtained a M.Sc. degree in Applied Health Economics from HEC Montréal between 2009 and 2010. This degree likely supported their understanding of the financial implications and economic evaluation of healthcare policies and interventions.

Lastly, Gabriel Tremblay completed their Bachelor of Arts (B.A.) degree in Economics from Université Laval from 2006 to 2008. This foundational education may have given him a broader understanding of economic principles and their application in various industries.

Overall, Gabriel Tremblay's academic journey shows a strong commitment to specialized knowledge in health economics, healthcare decision making, and health technology assessment, with a comprehensive understanding of business administration principles.